Rigel Pharmaceuticals

$3.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-1.81%) Today
-$0.01 (-0.31%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RIGL and other stocks, options, and ETFs commission-free!

About RIGL

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.

CEO
Raul R. Rodriguez
Employees
169
Headquarters
South San Francisco, California
Founded
1996
Market Cap
557.68M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.89M
High Today
$3.30
Low Today
$3.22
Open Price
$3.30
Volume
1.53M
52 Week High
$5.50
52 Week Low
$1.45

RIGL Earnings

-$0.13
-$0.04
$0.04
$0.13
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, After Hours

You May Also Like

PCG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure